Debevoise Advises Symbiotic in Inaugural Fundraise of More Than $600M
August 09, 2024
August 09, 2024
NEW YORK, Aug. 9 -- Debevoise and Plimpton, a law firm, issued the following news:
Debevoise & Plimpton LLP has advised Symbiotic Capital in its inaugural fundraising of more than $600 million in capital committed and targeted for investments and co-investments. For more information, read the company's press release.
Symbiotic Capital is a global life science credit firm.
The Debevoise team was led by investment management partners Sally Bergmann H . . .
Debevoise & Plimpton LLP has advised Symbiotic Capital in its inaugural fundraising of more than $600 million in capital committed and targeted for investments and co-investments. For more information, read the company's press release.
Symbiotic Capital is a global life science credit firm.
The Debevoise team was led by investment management partners Sally Bergmann H . . .